Exec Chairman Wayne Deveydt Sells 168130 Shares of Surgery Partners

December 27, 2023

☀️Trending News

Surgery Partners ($NASDAQ:SGRY) Inc. is a leading healthcare services and management company dedicated to providing surgical solutions for physicians in a variety of specialties. The company provides an array of services, including the development, acquisition, and management of single- and multi-specialty ambulatory surgical centers, as well as other related aspects of healthcare delivery. Surgery Partners’ stock currently trades on the NASDAQ under the ticker symbol SRGY. This news of Deveydt selling off such a large number of shares has caused some investors to question the company’s future performance.

However, most analysts believe that this move is part of a larger effort by the executive chairman to diversify his personal investments. With Surgery Partners continuing to expand its offerings and services, many believe that this move could potentially prove beneficial for the company in the long run.

Share Price

On Tuesday, Surgery Partners Inc. (SURGERY PARTNERS) saw their stock open at $32.4 and close at $32.3, up 0.2% from their previous closing price of $32.2. The implications of the sale remain unclear, and it will be interesting to see how the stock responds in the days and weeks ahead. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Surgery Partners. More…

    Total Revenues Net Income Net Margin
    2.71k -34.3 2.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Surgery Partners. More…

    Operations Investing Financing
    238.4 -239.7 82.5
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Surgery Partners. More…

    Total Assets Total Liabilities Book Value Per Share
    6.78k 3.46k 15.85
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Surgery Partners are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    14.1% 20.4% 11.8%
    FCF Margin ROE ROA
    5.4% 10.0% 3.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we take a closer look at the financials of SURGERY PARTNERS. Our Star Chart shows that the company has a high health score of 8/10, indicating that its cashflows and debt are capable to sustain future operations in times of crisis. We also classify the company as a ‘cheetah’ – these are companies which have achieved high revenue or earnings growth but are considered less stable due to lower profitability. From our analysis, it is clear that SURGERY PARTNERS is strong in assets, growth, and medium in profitability and weak in dividend payments. This type of company may be attractive to value investors, who are seeking companies with undervalued assets and low debt levels, or to growth investors looking for companies with potential for rapid expansion. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    It is one of the largest surgical providers in the country and faces competition from other providers such as Cross Country Healthcare Inc, Genesis Healthcare Inc, and PT Mitra Keluarga Karyasehat Tbk. All of these companies provide quality healthcare services for their respective markets and have an established presence in the surgical services sector.

    – Cross Country Healthcare Inc ($NASDAQ:CCRN)

    Cross Country Healthcare Inc is a leading provider of healthcare staffing and workforce solutions. With a market cap of 1.04 billion as of 2023, the company is well-positioned to capitalize on the growing demand for its services. Cross Country Healthcare Inc’s Return on Equity of 44.54% reflects the fact that the company is generating strong returns for its shareholders. The company offers a variety of solutions, from short-term staffing to long-term strategic workforce planning, that can help healthcare facilities optimize their staffing and operations. With its highly experienced team and industry-leading solutions, Cross Country Healthcare Inc is well positioned to continue to be a leader in the healthcare staffing space.

    – Genesis Healthcare Inc ($OTCPK:GENN)

    Genesis Healthcare Inc is a leading national provider of post-acute care services, offering long-term care and rehabilitation services at more than 500 skilled nursing centers and assisted/senior living communities in 34 states. As of 2023, the company has a market cap of 1.97M, indicating its relative small size compared to other healthcare providers. Despite its small size, Genesis Healthcare Inc has performed relatively well, evidenced by its Return on Equity of -2.17%. This metric is a measure of how much profit a company is able to generate from its shareholders’ investments, and a negative number indicates that the company is not generating a sufficient return on equity.

    – PT Mitra Keluarga Karyasehat Tbk ($IDX:MIKA)

    PT Mitra Keluarga Karyasehat Tbk is a leading provider of health and wellness services in Indonesia. The company has a current market cap of 42.7T, making it one of the largest companies in the country. PT Mitra Keluarga Karyasehat Tbk has achieved a remarkable 18.07% Return on Equity, which indicates that the company is able to generate a significant return on its shareholders’ equity. This demonstrates the company’s ability to efficiently manage its resources and generate a healthy return for its shareholders.

    Summary

    Surgery Partners Inc. is a healthcare services company that provides surgical solutions and services to hospitals, physicians and other healthcare providers. This could be an indication that the company’s stock is overvalued and insiders may be looking to capitalize on current prices. Investors should note that any major insider selloff could be a warning sign of potential losses in the future.

    As such, they should analyze the company further before investing. Such analysis could include researching the company’s financials, competitive landscape, management team and industry outlook to make an informed decision.

    Recent Posts

    Leave a Comment